261 related articles for article (PubMed ID: 10698197)
1. The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats.
Hill C; Flyvbjerg A; Grønbaek H; Petrik J; Hill DJ; Thomas CR; Sheppard MC; Logan A
Endocrinology; 2000 Mar; 141(3):1196-208. PubMed ID: 10698197
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney.
Hill C; Flyvbjerg A; Rasch R; Bak M; Logan A
J Endocrinol; 2001 Sep; 170(3):647-51. PubMed ID: 11524245
[TBL] [Abstract][Full Text] [Related]
3. Effects of diabetes and hypertension on glomerular transforming growth factor-beta receptor expression.
Kang MJ; Ingram A; Ly H; Thai K; Scholey JW
Kidney Int; 2000 Oct; 58(4):1677-85. PubMed ID: 11012901
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.
Hill C; Logan A; Smith C; Grønbaek H; Flyvbjerg A
Diabetologia; 2001 Apr; 44(4):495-500. PubMed ID: 11357481
[TBL] [Abstract][Full Text] [Related]
5. Increased renal GLUT1 abundance and urinary TGF-beta 1 in streptozotocin-induced diabetic rats: implications for the development of nephropathy complicating diabetes.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Horm Metab Res; 2001 Nov; 33(11):664-9. PubMed ID: 11733869
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
Kalender B; Oztürk M; Tunçdemir M; Uysal O; Dagistanli FK; Yegenaga I; Erek E
Acta Histochem; 2002; 104(2):123-30. PubMed ID: 12086332
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms through which bradykinin promotes glomerular injury in diabetes.
Tan Y; Wang B; Keum JS; Jaffa AA
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F483-92. PubMed ID: 15692059
[TBL] [Abstract][Full Text] [Related]
8. [Losartan downregulates the expression of transforming growth factor beta type I and type II receptors in kidney of diabetic rat].
Guo ZX; Qiu MC
Zhonghua Nei Ke Za Zhi; 2003 Jun; 42(6):403-8. PubMed ID: 12895325
[TBL] [Abstract][Full Text] [Related]
9. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.
Park IS; Kiyomoto H; Abboud SL; Abboud HE
Diabetes; 1997 Mar; 46(3):473-80. PubMed ID: 9032105
[TBL] [Abstract][Full Text] [Related]
10. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats.
Reddi AS; Bollineni JS
Kidney Int; 2001 Apr; 59(4):1342-53. PubMed ID: 11260395
[TBL] [Abstract][Full Text] [Related]
11. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta in acute renal failure: receptor expression, effects on proliferation, cellularity, and vascularization after recovery from injury.
Spurgeon KR; Donohoe DL; Basile DP
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F568-77. PubMed ID: 15536165
[TBL] [Abstract][Full Text] [Related]
13. Experimental diabetes-induced regression of the rat prostate is associated with an increased expression of transforming growth factor-beta.
Ikeda K; Wada Y; Foster HE; Wang Z; Weiss RM; Latifpour J
J Urol; 2000 Jul; 164(1):180-5. PubMed ID: 10840456
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the transforming growth factor beta1 by vitamin E in early nephropathy.
Cojocel C; Al-Maghrebi M; Thomson MS; Rawoot P; Raghupathy R
Med Princ Pract; 2005; 14(6):422-9. PubMed ID: 16220017
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
16. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
Volpini RA; da Silva CG; Costa RS; Coimbra TM
Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
[TBL] [Abstract][Full Text] [Related]
17. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
Russo LM; del Re E; Brown D; Lin HY
Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
[TBL] [Abstract][Full Text] [Related]
19. [Changes of bone morphogenetic protein-7 and inhibitory Smad expression in streptozotocin-induced diabetic nephropathy rat kidney].
Yang Q; Han B; Xie RJ; Cheng ML
Sheng Li Xue Bao; 2007 Apr; 59(2):190-6. PubMed ID: 17437042
[TBL] [Abstract][Full Text] [Related]
20. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1a receptor.
Okazaki Y; Yamasaki Y; Uchida HA; Okamoto K; Satoh M; Maruyama K; Maeshima Y; Sugiyama H; Sugaya T; Kashihara N; Makino H
Clin Exp Nephrol; 2007 Mar; 11(1):77-87. PubMed ID: 17385003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
